查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
2030 年細胞遺傳學市場預測：按產品、技術、用途、最終用戶和地區進行的全球分析
市場調查報告書
商品編碼
1372035

2030 年細胞遺傳學市場預測：按產品、技術、用途、最終用戶和地區進行的全球分析

Cytogenetics Market Forecasts to 2030 - Global Analysis By Product, Technique, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，2023 年全球細胞遺傳學市場規模為 27 億美元，預計在預測期內年複合成長率為 11.8%，到 2030 年將達到 61 億美元。

對染色體、基因及其在生物體結構中的結構和數值變異的研究屬於細胞遺傳學的廣泛範疇，其中包括廣泛的方法、設備和服務。細胞遺傳學是一個重要的領域，有助於發現遺傳異常、檢測遺傳疾病以及了解癌症等疾病的遺傳背景。其應用領域為臨床診斷、研究和個人化醫療。

根據世界衛生組織統計，2018年約有1,810萬人新診斷出癌症，960萬人死於癌症。

對細胞遺傳學的高需求

細胞遺傳學需求增加的原因有很多。首先，它對於了解癌症、出生缺陷和遺傳疾病至關重要。此外，隨著精準醫療的普及，基因診斷和個體化治療計畫變得越來越重要。此外，由於人們對遺傳對健康和疾病的影響以及高齡化的認知不斷加深，臨床、研究和診斷用途對細胞遺傳學檢測的需求不斷增加。因此，擴大人類基因組和疾病遺傳學研究的需求不斷增加。

高成本

細胞遺傳學檢測需要使用專門的工具、消耗品和訓練有素的人員，所有這些都是昂貴的。患者通常需要申請這些費用，並且接受基因診斷和諮詢的能力受到限制。它也可能給醫院和研究機構造成財務困難。新細胞遺傳學技術的創建和使用也受到高成本的阻礙。因此，這些方面都阻礙了市場的成長。

癌症治療的新創新

隨著癌症發生率的增加，許多分子細胞遺傳學技術經常用於癌症診斷。此外，隨著我們對染色體層面上癌症的了解不斷加深，在癌症研究成長的推動下，細胞遺傳學收益也不斷擴大。例如，FISH 和 CGH 技術的使用促進了該市場的開拓，這些技術提供了與癌症相關的遺傳標記的重要資訊。 FISH、染色體影像分析、流式分選和基因組原位雜合技術 (GISH) 是用於創建合成植物染色體的方法，並已用於創建遺傳、物理、分子和比較圖譜。此外，分子細胞遺傳學在作物改良中的應用領域和優勢的擴大正在支持市場的成長。

不利的報酬

不利的薪酬做法對細胞遺傳學產業有害。由於付款不一致或不足，醫療保健提供者不太可能進行細胞遺傳學檢測和治療，從而限制了患者的訪問。此外，這也透過減少需求和降低研發的經濟誘因來影響市場。此外，關於獲得尖端細胞遺傳學檢測的衝突可能會阻止患者接受癌症和遺傳性疾病等疾病的重要基因診斷。這是市場拓展的一大障礙。

COVID-19 的影響

細胞遺傳學市場受到了 COVID-19大流行的負面影響。封鎖和資源重新分配擾亂了實驗室業務，導致基因檢測延遲和患者准入問題。此外，經濟不確定性限制了研究和測試項目的資金，供應鏈中斷阻礙了獲得所需的測試用品。此外，學術和臨床研究活動也受到阻礙，導致臨床和科學挫折。因此，這些要素極大地阻礙了市場的成長。

預計核型測試領域在預測期內將是最大的。

據估計，核型分析部分佔最大佔有率。它通常從血液或組織樣本中可視化並檢查一個人的整個染色體。此外，核型分析有助於檢測染色體結構和數值異常，有助於癌症、遺傳性疾病和產前檢測的診斷。此外，雖然更先進的技術（例如光譜核型分析和螢光原位雜合技術（FISH））提供了更高的解析度，但傳統的核型分析程序（包括染色體染色和顯微鏡檢查）將會出現。因此，核型分析因其對染色體異常和遺傳疾病的寶貴見解而仍然是臨床和研究細胞遺傳學的基石。

個人化醫療領域預計在預測期內年複合成長率最高

由於根據患者個人化醫療調整醫療照護的領域迅速擴大，預計個人化醫療領域在預測期內將出現最高的年複合成長率。細胞遺傳學程序，例如染色體分析和分子測試，使臨床醫生能夠發現影響藥物治療反應、疾病易感性和整體健康的遺傳差異。此外，該方法可以更準確地診斷和治療選擇，改善治療結果並減少不良反應。此外，隨著基因組學和細胞遺傳學技術的進步，個人化醫療在罕見疾病、藥物基因組學和癌症的鑒定中發揮關鍵作用，根據患者的基因圖譜提供個體化的標靶治療方案，從而徹底改變醫療保健。因此，有利於擴大市場規模。

比最大的地區

由於世界各國政府和學術機構透過資助和配合措施積極鼓勵基因研究和診斷，亞太地區在估計期間獲得了最大的市場佔有率。例如，印度的「印度基因組計畫」正試圖創建印度基因組的綜合圖譜。此外，中國和日本等國家正在啟動基因組學配合措施，以推進基因診斷和個人化醫療。此外，亞太地區正在成為基因研究、創新和臨床應用的焦點，這些計畫得到了大量多樣化人口的支持。

複合年複合成長率最高的地區：

由於著名的研究機構、生物技術公司和醫療設施位於該地區，支持細胞遺傳學的創新和研究，預計北美在預測期內將出現有益的成長。此外，強大的醫療保健系統和積極的政府政策促進了細胞遺傳學檢測融入臨床實踐，促進個人化醫療和精準醫療。此外，由於北美在細胞遺傳學方面的領先地位和強大的法規環境，該地區處於基因診斷和研究的前沿，推動了市場的成長和進步。

免費客製化服務

訂閱此報告的客戶可以存取以下免費自訂選項之一：

  • 公司簡介
    • 其他市場參與者的綜合分析（最多 3 家公司）
    • 主要企業SWOT分析（最多3家企業）
  • 區域分割
    • 根據客戶興趣對主要國家的市場估計、預測和年複合成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章 執行摘要

第2章 前言

  • 概述
  • 利害關係人
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 調查來源
    • 主要調查來源
    • 二次調查來源
    • 先決條件

第3章 市場趨勢分析

  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 產品分析
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • 新型冠狀病毒感染疾病（COVID-19）的影響

第4章 波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章 全球細胞遺傳學市場：依產品

  • 消耗品
    • 檢測套組、培養基和試劑
    • 探測
    • 親和試劑和染色劑
    • 其他消耗品
  • 樂器
  • 軟體和服務
  • 其他產品

第6章 全球細胞遺傳學市場：依技術分類

  • 比較基因組雜交
  • 螢光原位雜合技術
  • 核型分析
  • 免疫組織化學
  • 其他技術

第7章 全球細胞遺傳學市場：依應用分類

  • 遺傳疾病
  • 癌症
  • 個人化醫療
  • 其他用途

第8章 全球細胞遺傳學市場：依最終用戶分類

  • 臨床研究室
  • 製藥和生物技術公司
  • 學術研究
  • 其他最終用戶

第9章 全球細胞遺傳學市場：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲

第10章 進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第11章公司簡介

  • Thermo Fisher Scientific, Inc.
  • Sysmex Corporation
  • PerkinElmer, Inc.
  • OPKO Health, Inc.
  • Irvine Scientific
  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Applied Spectrial Imaging, Inc.
  • Empire Genomics, LLC
Product Code: SMRC24091

According to Stratistics MRC, the Global Cytogenetics Market is accounted for $2.7 billion in 2023 and is expected to reach $6.1 billion by 2030 growing at a CAGR of 11.8% during the forecast period. The study of chromosomes, genes, and their structural and numerical variations within an organism's genetic makeup falls under the broad category of cytogenetics, which includes a wide range of methods, instruments, and services. It helps in locating genetic anomalies, detecting genetic disorders, and comprehending the genetic underpinnings of diseases like cancer, this field is crucial. Its applications are in clinical diagnostics, research, and personalized medicine.

According to WHO, in the year 2018 around 18.1 million new cases were diagnosed and 9.6 million individuals died out of cancer.

Market Dynamics:

Driver:

High demand for cytogenetics

Numerous reasons have contributed to the rise in cytogenetic demand. First of all, it is essential to comprehending cancer, birth deformities, and hereditary diseases. Moreover, genetic diagnosis and individualized treatment plans are becoming more and more important as precision medicine becomes more and more popular, cytogenetic testing is now more widely available, precise, and economical thanks to technological improvements. Furthermore, the demand for cytogenetics in clinical, research, and diagnostic applications keeps rising as a result of expanding understanding of the genetic contributions to health and illness as well as an aging population. Therefore, the expansion of research into the human genome and the genetics of diseases have increased demand.

Restraint:

High cost

Cytogenetic testing necessitates the use of specialized tools, consumables, and trained workers, all of which can be expensive. Patients are frequently charged for these costs, which restricts their ability to get genetic diagnostics and counseling. They can present financial difficulties for hospitals and research facilities. The creation and use of new cytogenetic technologies are also hampered by high costs. Hence, these aspects hinder the market growth.

Opportunity:

New innovations in cancer treatment

Numerous molecular cytogenetics techniques are being employed more frequently for cancer diagnosis as the incidence of the disease rises. In addition, as more is understood about cancer at the chromosomal level, this is causing the cytogenetics revenue to expand, which is being fueled by the growth of cancer research. For instance, the development of the market is facilitated by the use of FISH and CGH procedures, which offer vital information on cancer-related genetic markers. FISH, chromosomal image analysis, flow sorting, and genomic in-situ hybridization (GISH), methods used for the creation of synthetic plant chromosomes, are employed in the creation of genetic, physical, molecular, and comparative maps. Moreover, the rising application field and advantages of molecular cytogenetics in crop improvement are therefore assisting the market's growth.

Threat:

Unfavourable compensation

Unfavourable reimbursement practices have been detrimental to the cytogenetics industry. Healthcare providers are less likely to give cytogenetic testing and treatments as a result of inconsistent or insufficient payment, which restricts patient access. Moreover, in turn, this has an impact on the market by decreasing demand and the financial incentives for R&D. Additionally, it may result in disagreements over access to cutting-edge cytogenetic testing, preventing patients from receiving vital genetic diagnostics for diseases like cancer and genetic disorders. Therefore, it is significantly hindering market expansion.

COVID-19 Impact

The cytogenetics market was negatively impacted by the COVID-19 pandemic. Due to lockdowns and resource redistribution, it interfered with laboratory operations, causing delays in genetic testing and problems with patient access. Furthermore, economic uncertainty limited funding for research and testing projects, while supply chain interruptions hindered the accessibility of necessary testing supplies. Moreover, academic and clinical research operations were impeded, which resulted in clinical and scientific setbacks. Therefore, these factors significantly hampered the market growth.

The karyotyping segment is expected to be the largest during the forecast period

The karyotyping segment is estimated to hold the largest share. It entails the visualization and examination of a person's whole chromosomal set, usually from a blood or tissue sample. Additionally, karyotyping aids in the detection of chromosomal structure and numerical anomalies, which aid in the diagnosis of cancer, genetic diseases, and prenatal testing. Moreover, more sophisticated techniques like spectral karyotyping and fluorescent in situ hybridization (FISH) offer higher resolution, traditional karyotyping procedures include staining and microscopic inspection of chromosomes. Therefore, with the invaluable insights into chromosomal abnormalities and genetic illnesses, karyotyping continues to be a cornerstone in clinical and research cytogenetics.

The personalized medicine segment is expected to have the highest CAGR during the forecast period

The personalized medicine segment is anticipated to have highest CAGR during the forecast period, due to a quickly expanding area that adapts medical care to a patient's genetic profile. Clinicians can find genetic differences that affect a person's response to medication, susceptibility to diseases, and general health by utilizing cytogenetic procedures such as chromosomal analysis and molecular testing. Additionally, this method allows for more exact diagnostic and treatment choices, improving therapeutic results and reducing negative effects. Moreover, with improvements in genomics and cytogenetic technology, personalized medicine is playing a crucial role in the identification of uncommon diseases, pharmacogenomics, and cancers, revolutionizing healthcare by offering patients personalized and targeted treatment plans based on their genetic profiles. Thus, helps in expanding the market size.

Region with largest share:

Asia Pacific commanded the largest market share during the extrapolated period owing to a number of initiatives, through funding and cooperative initiatives, governments and academic institutions from all around the region are actively encouraging genetic research and diagnostics. For instance, the "Genome India Project" in India attempts to produce an exhaustive map of the Indian genome. Moreover, nations like China and Japan have launched genomics efforts to advance genetic diagnoses and tailored medicine. Furthermore, the Asia-Pacific area is becoming a focus point for genetic studies, innovations, and clinical applications due to these programs, which are supported by a sizable and diversified population.

Region with highest CAGR:

North America is expected to witness profitable growth over the projection period, owing to renowned research institutions, biotech firms, and medical facilities are located in the area, which supports cytogenetics innovation and study. Additionally, robust healthcare systems and proactive government policies have made it easier to incorporate cytogenetic testing into clinical practice, promoting personalized and precision medicine. Furthermore, the region is at the forefront of genetic diagnostics and research due to North America's leadership in cytogenetics and a strong regulatory environment, which promotes market growth and advancements.

Key players in the market:

Some of the key players in the Cytogenetics Market include: Thermo Fisher Scientific Inc., Sysmex Corporation, PerkinElmer, Inc., OPKO Health, Inc., Irvine Scientific, Abbott Laboratories, Agilent Technologies, Inc., Applied Spectrial Imaging, Inc. and Empire Genomics, LLC.

Key Developments:

In September 2023, Abbott announced it has completed the acquisition of Bigfoot Biomedical, a leader in developing smart insulin management systems for people with diabetes.

In August 2023, Thermo Fisher Scientific Inc. the world leader in serving science, announced that it has completed the acquisition of CorEvitas, LLC ("CorEvitas"), a leading provider of regulatory-grade, real-world evidence for approved medical treatments and therapies, from Audax Private Equity ("Audax).

In August 2023, Thermo Fisher Scientific, the world leader in serving science, announced the commercial launch of the EXENT® Solution, after receiving IVDR certification*. The EXENT solution is a fully integrated and automated mass spectrometry system designed to transform diagnosis and assessment for patients with monoclonal gammopathies, including multiple myeloma.

Products Covered:

  • Consumable
  • Instrument
  • Software & Service
  • Other Products

Techniques Covered:

  • Comparitive Genome Hybridization
  • Fluorescence In Situ Hybridization
  • Karyotyping
  • Immunohistochemistry
  • Other Techniques

Applications Covered:

  • Genetic Disorder
  • Cancer
  • Personalized Medicine
  • Other Applications

End Users Covered:

  • Clinical and Research Laboratory
  • Pharmaceutical and Biotechnology Company
  • Academic Research Institute
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Cytogenetics Market, By Product

  • 5.1 Introduction
  • 5.2 Consumable
    • 5.2.1 Testing Kits, Media, and Reagents
    • 5.2.2 Probes
    • 5.2.3 Affinity Reagents and Stains
    • 5.2.4 Other Consumables
  • 5.3 Instrument
  • 5.4 Software & Service
  • 5.5 Other Products

6 Global Cytogenetics Market, By Technique

  • 6.1 Introduction
  • 6.2 Comparitive Genome Hybridization
  • 6.3 Fluorescence In Situ Hybridization
  • 6.4 Karyotyping
  • 6.5 Immunohistochemistry
  • 6.6 Other Techniques

7 Global Cytogenetics Market, By Application

  • 7.1 Introduction
  • 7.2 Genetic Disorder
  • 7.3 Cancer
  • 7.4 Personalized Medicine
  • 7.5 Other Applications

8 Global Cytogenetics Market, By End User

  • 8.1 Introduction
  • 8.2 Clinical and Research Laboratory
  • 8.3 Pharmaceutical and Biotechnology Company
  • 8.4 Academic Research Institute
  • 8.5 Other End Users

9 Global Cytogenetics Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Thermo Fisher Scientific, Inc.
  • 11.2 Sysmex Corporation
  • 11.3 PerkinElmer, Inc.
  • 11.4 OPKO Health, Inc.
  • 11.5 Irvine Scientific
  • 11.6 Abbott Laboratories
  • 11.7 Agilent Technologies, Inc.
  • 11.8 Applied Spectrial Imaging, Inc.
  • 11.9 Empire Genomics, LLC

List of Tables

  • Table 1 Global Cytogenetics Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Cytogenetics Market Outlook, By Product (2021-2030) ($MN)
  • Table 3 Global Cytogenetics Market Outlook, By Consumable (2021-2030) ($MN)
  • Table 4 Global Cytogenetics Market Outlook, By Testing Kits, Media, and Reagents (2021-2030) ($MN)
  • Table 5 Global Cytogenetics Market Outlook, By Probes (2021-2030) ($MN)
  • Table 6 Global Cytogenetics Market Outlook, By Affinity Reagents and Stains (2021-2030) ($MN)
  • Table 7 Global Cytogenetics Market Outlook, By Other Consumables (2021-2030) ($MN)
  • Table 8 Global Cytogenetics Market Outlook, By Instrument (2021-2030) ($MN)
  • Table 9 Global Cytogenetics Market Outlook, By Software & Service (2021-2030) ($MN)
  • Table 10 Global Cytogenetics Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 11 Global Cytogenetics Market Outlook, By Technique (2021-2030) ($MN)
  • Table 12 Global Cytogenetics Market Outlook, By Comparitive Genome Hybridization (2021-2030) ($MN)
  • Table 13 Global Cytogenetics Market Outlook, By Fluorescence In Situ Hybridization (2021-2030) ($MN)
  • Table 14 Global Cytogenetics Market Outlook, By Karyotyping (2021-2030) ($MN)
  • Table 15 Global Cytogenetics Market Outlook, By Immunohistochemistry (2021-2030) ($MN)
  • Table 16 Global Cytogenetics Market Outlook, By Other Techniques (2021-2030) ($MN)
  • Table 17 Global Cytogenetics Market Outlook, By Application (2021-2030) ($MN)
  • Table 18 Global Cytogenetics Market Outlook, By Genetic Disorder (2021-2030) ($MN)
  • Table 19 Global Cytogenetics Market Outlook, By Cancer (2021-2030) ($MN)
  • Table 20 Global Cytogenetics Market Outlook, By Personalized Medicine (2021-2030) ($MN)
  • Table 21 Global Cytogenetics Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 22 Global Cytogenetics Market Outlook, By End User (2021-2030) ($MN)
  • Table 23 Global Cytogenetics Market Outlook, By Clinical and Research Laboratory (2021-2030) ($MN)
  • Table 24 Global Cytogenetics Market Outlook, By Pharmaceutical and Biotechnology Company (2021-2030) ($MN)
  • Table 25 Global Cytogenetics Market Outlook, By Academic Research Institute (2021-2030) ($MN)
  • Table 26 Global Cytogenetics Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 27 North America Cytogenetics Market Outlook, By Country (2021-2030) ($MN)
  • Table 28 North America Cytogenetics Market Outlook, By Product (2021-2030) ($MN)
  • Table 29 North America Cytogenetics Market Outlook, By Consumable (2021-2030) ($MN)
  • Table 30 North America Cytogenetics Market Outlook, By Testing Kits, Media, and Reagents (2021-2030) ($MN)
  • Table 31 North America Cytogenetics Market Outlook, By Probes (2021-2030) ($MN)
  • Table 32 North America Cytogenetics Market Outlook, By Affinity Reagents and Stains (2021-2030) ($MN)
  • Table 33 North America Cytogenetics Market Outlook, By Other Consumables (2021-2030) ($MN)
  • Table 34 North America Cytogenetics Market Outlook, By Instrument (2021-2030) ($MN)
  • Table 35 North America Cytogenetics Market Outlook, By Software & Service (2021-2030) ($MN)
  • Table 36 North America Cytogenetics Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 37 North America Cytogenetics Market Outlook, By Technique (2021-2030) ($MN)
  • Table 38 North America Cytogenetics Market Outlook, By Comparitive Genome Hybridization (2021-2030) ($MN)
  • Table 39 North America Cytogenetics Market Outlook, By Fluorescence In Situ Hybridization (2021-2030) ($MN)
  • Table 40 North America Cytogenetics Market Outlook, By Karyotyping (2021-2030) ($MN)
  • Table 41 North America Cytogenetics Market Outlook, By Immunohistochemistry (2021-2030) ($MN)
  • Table 42 North America Cytogenetics Market Outlook, By Other Techniques (2021-2030) ($MN)
  • Table 43 North America Cytogenetics Market Outlook, By Application (2021-2030) ($MN)
  • Table 44 North America Cytogenetics Market Outlook, By Genetic Disorder (2021-2030) ($MN)
  • Table 45 North America Cytogenetics Market Outlook, By Cancer (2021-2030) ($MN)
  • Table 46 North America Cytogenetics Market Outlook, By Personalized Medicine (2021-2030) ($MN)
  • Table 47 North America Cytogenetics Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 48 North America Cytogenetics Market Outlook, By End User (2021-2030) ($MN)
  • Table 49 North America Cytogenetics Market Outlook, By Clinical and Research Laboratory (2021-2030) ($MN)
  • Table 50 North America Cytogenetics Market Outlook, By Pharmaceutical and Biotechnology Company (2021-2030) ($MN)
  • Table 51 North America Cytogenetics Market Outlook, By Academic Research Institute (2021-2030) ($MN)
  • Table 52 North America Cytogenetics Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 53 Europe Cytogenetics Market Outlook, By Country (2021-2030) ($MN)
  • Table 54 Europe Cytogenetics Market Outlook, By Product (2021-2030) ($MN)
  • Table 55 Europe Cytogenetics Market Outlook, By Consumable (2021-2030) ($MN)
  • Table 56 Europe Cytogenetics Market Outlook, By Testing Kits, Media, and Reagents (2021-2030) ($MN)
  • Table 57 Europe Cytogenetics Market Outlook, By Probes (2021-2030) ($MN)
  • Table 58 Europe Cytogenetics Market Outlook, By Affinity Reagents and Stains (2021-2030) ($MN)
  • Table 59 Europe Cytogenetics Market Outlook, By Other Consumables (2021-2030) ($MN)
  • Table 60 Europe Cytogenetics Market Outlook, By Instrument (2021-2030) ($MN)
  • Table 61 Europe Cytogenetics Market Outlook, By Software & Service (2021-2030) ($MN)
  • Table 62 Europe Cytogenetics Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 63 Europe Cytogenetics Market Outlook, By Technique (2021-2030) ($MN)
  • Table 64 Europe Cytogenetics Market Outlook, By Comparitive Genome Hybridization (2021-2030) ($MN)
  • Table 65 Europe Cytogenetics Market Outlook, By Fluorescence In Situ Hybridization (2021-2030) ($MN)
  • Table 66 Europe Cytogenetics Market Outlook, By Karyotyping (2021-2030) ($MN)
  • Table 67 Europe Cytogenetics Market Outlook, By Immunohistochemistry (2021-2030) ($MN)
  • Table 68 Europe Cytogenetics Market Outlook, By Other Techniques (2021-2030) ($MN)
  • Table 69 Europe Cytogenetics Market Outlook, By Application (2021-2030) ($MN)
  • Table 70 Europe Cytogenetics Market Outlook, By Genetic Disorder (2021-2030) ($MN)
  • Table 71 Europe Cytogenetics Market Outlook, By Cancer (2021-2030) ($MN)
  • Table 72 Europe Cytogenetics Market Outlook, By Personalized Medicine (2021-2030) ($MN)
  • Table 73 Europe Cytogenetics Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 74 Europe Cytogenetics Market Outlook, By End User (2021-2030) ($MN)
  • Table 75 Europe Cytogenetics Market Outlook, By Clinical and Research Laboratory (2021-2030) ($MN)
  • Table 76 Europe Cytogenetics Market Outlook, By Pharmaceutical and Biotechnology Company (2021-2030) ($MN)
  • Table 77 Europe Cytogenetics Market Outlook, By Academic Research Institute (2021-2030) ($MN)
  • Table 78 Europe Cytogenetics Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 79 Asia Pacific Cytogenetics Market Outlook, By Country (2021-2030) ($MN)
  • Table 80 Asia Pacific Cytogenetics Market Outlook, By Product (2021-2030) ($MN)
  • Table 81 Asia Pacific Cytogenetics Market Outlook, By Consumable (2021-2030) ($MN)
  • Table 82 Asia Pacific Cytogenetics Market Outlook, By Testing Kits, Media, and Reagents (2021-2030) ($MN)
  • Table 83 Asia Pacific Cytogenetics Market Outlook, By Probes (2021-2030) ($MN)
  • Table 84 Asia Pacific Cytogenetics Market Outlook, By Affinity Reagents and Stains (2021-2030) ($MN)
  • Table 85 Asia Pacific Cytogenetics Market Outlook, By Other Consumables (2021-2030) ($MN)
  • Table 86 Asia Pacific Cytogenetics Market Outlook, By Instrument (2021-2030) ($MN)
  • Table 87 Asia Pacific Cytogenetics Market Outlook, By Software & Service (2021-2030) ($MN)
  • Table 88 Asia Pacific Cytogenetics Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 89 Asia Pacific Cytogenetics Market Outlook, By Technique (2021-2030) ($MN)
  • Table 90 Asia Pacific Cytogenetics Market Outlook, By Comparitive Genome Hybridization (2021-2030) ($MN)
  • Table 91 Asia Pacific Cytogenetics Market Outlook, By Fluorescence In Situ Hybridization (2021-2030) ($MN)
  • Table 92 Asia Pacific Cytogenetics Market Outlook, By Karyotyping (2021-2030) ($MN)
  • Table 93 Asia Pacific Cytogenetics Market Outlook, By Immunohistochemistry (2021-2030) ($MN)
  • Table 94 Asia Pacific Cytogenetics Market Outlook, By Other Techniques (2021-2030) ($MN)
  • Table 95 Asia Pacific Cytogenetics Market Outlook, By Application (2021-2030) ($MN)
  • Table 96 Asia Pacific Cytogenetics Market Outlook, By Genetic Disorder (2021-2030) ($MN)
  • Table 97 Asia Pacific Cytogenetics Market Outlook, By Cancer (2021-2030) ($MN)
  • Table 98 Asia Pacific Cytogenetics Market Outlook, By Personalized Medicine (2021-2030) ($MN)
  • Table 99 Asia Pacific Cytogenetics Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 100 Asia Pacific Cytogenetics Market Outlook, By End User (2021-2030) ($MN)
  • Table 101 Asia Pacific Cytogenetics Market Outlook, By Clinical and Research Laboratory (2021-2030) ($MN)
  • Table 102 Asia Pacific Cytogenetics Market Outlook, By Pharmaceutical and Biotechnology Company (2021-2030) ($MN)
  • Table 103 Asia Pacific Cytogenetics Market Outlook, By Academic Research Institute (2021-2030) ($MN)
  • Table 104 Asia Pacific Cytogenetics Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 105 South America Cytogenetics Market Outlook, By Country (2021-2030) ($MN)
  • Table 106 South America Cytogenetics Market Outlook, By Product (2021-2030) ($MN)
  • Table 107 South America Cytogenetics Market Outlook, By Consumable (2021-2030) ($MN)
  • Table 108 South America Cytogenetics Market Outlook, By Testing Kits, Media, and Reagents (2021-2030) ($MN)
  • Table 109 South America Cytogenetics Market Outlook, By Probes (2021-2030) ($MN)
  • Table 110 South America Cytogenetics Market Outlook, By Affinity Reagents and Stains (2021-2030) ($MN)
  • Table 111 South America Cytogenetics Market Outlook, By Other Consumables (2021-2030) ($MN)
  • Table 112 South America Cytogenetics Market Outlook, By Instrument (2021-2030) ($MN)
  • Table 113 South America Cytogenetics Market Outlook, By Software & Service (2021-2030) ($MN)
  • Table 114 South America Cytogenetics Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 115 South America Cytogenetics Market Outlook, By Technique (2021-2030) ($MN)
  • Table 116 South America Cytogenetics Market Outlook, By Comparitive Genome Hybridization (2021-2030) ($MN)
  • Table 117 South America Cytogenetics Market Outlook, By Fluorescence In Situ Hybridization (2021-2030) ($MN)
  • Table 118 South America Cytogenetics Market Outlook, By Karyotyping (2021-2030) ($MN)
  • Table 119 South America Cytogenetics Market Outlook, By Immunohistochemistry (2021-2030) ($MN)
  • Table 120 South America Cytogenetics Market Outlook, By Other Techniques (2021-2030) ($MN)
  • Table 121 South America Cytogenetics Market Outlook, By Application (2021-2030) ($MN)
  • Table 122 South America Cytogenetics Market Outlook, By Genetic Disorder (2021-2030) ($MN)
  • Table 123 South America Cytogenetics Market Outlook, By Cancer (2021-2030) ($MN)
  • Table 124 South America Cytogenetics Market Outlook, By Personalized Medicine (2021-2030) ($MN)
  • Table 125 South America Cytogenetics Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 126 South America Cytogenetics Market Outlook, By End User (2021-2030) ($MN)
  • Table 127 South America Cytogenetics Market Outlook, By Clinical and Research Laboratory (2021-2030) ($MN)
  • Table 128 South America Cytogenetics Market Outlook, By Pharmaceutical and Biotechnology Company (2021-2030) ($MN)
  • Table 129 South America Cytogenetics Market Outlook, By Academic Research Institute (2021-2030) ($MN)
  • Table 130 South America Cytogenetics Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 131 Middle East & Africa Cytogenetics Market Outlook, By Country (2021-2030) ($MN)
  • Table 132 Middle East & Africa Cytogenetics Market Outlook, By Product (2021-2030) ($MN)
  • Table 133 Middle East & Africa Cytogenetics Market Outlook, By Consumable (2021-2030) ($MN)
  • Table 134 Middle East & Africa Cytogenetics Market Outlook, By Testing Kits, Media, and Reagents (2021-2030) ($MN)
  • Table 135 Middle East & Africa Cytogenetics Market Outlook, By Probes (2021-2030) ($MN)
  • Table 136 Middle East & Africa Cytogenetics Market Outlook, By Affinity Reagents and Stains (2021-2030) ($MN)
  • Table 137 Middle East & Africa Cytogenetics Market Outlook, By Other Consumables (2021-2030) ($MN)
  • Table 138 Middle East & Africa Cytogenetics Market Outlook, By Instrument (2021-2030) ($MN)
  • Table 139 Middle East & Africa Cytogenetics Market Outlook, By Software & Service (2021-2030) ($MN)
  • Table 140 Middle East & Africa Cytogenetics Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 141 Middle East & Africa Cytogenetics Market Outlook, By Technique (2021-2030) ($MN)
  • Table 142 Middle East & Africa Cytogenetics Market Outlook, By Comparitive Genome Hybridization (2021-2030) ($MN)
  • Table 143 Middle East & Africa Cytogenetics Market Outlook, By Fluorescence In Situ Hybridization (2021-2030) ($MN)
  • Table 144 Middle East & Africa Cytogenetics Market Outlook, By Karyotyping (2021-2030) ($MN)
  • Table 145 Middle East & Africa Cytogenetics Market Outlook, By Immunohistochemistry (2021-2030) ($MN)
  • Table 146 Middle East & Africa Cytogenetics Market Outlook, By Other Techniques (2021-2030) ($MN)
  • Table 147 Middle East & Africa Cytogenetics Market Outlook, By Application (2021-2030) ($MN)
  • Table 148 Middle East & Africa Cytogenetics Market Outlook, By Genetic Disorder (2021-2030) ($MN)
  • Table 149 Middle East & Africa Cytogenetics Market Outlook, By Cancer (2021-2030) ($MN)
  • Table 150 Middle East & Africa Cytogenetics Market Outlook, By Personalized Medicine (2021-2030) ($MN)
  • Table 151 Middle East & Africa Cytogenetics Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 152 Middle East & Africa Cytogenetics Market Outlook, By End User (2021-2030) ($MN)
  • Table 153 Middle East & Africa Cytogenetics Market Outlook, By Clinical and Research Laboratory (2021-2030) ($MN)
  • Table 154 Middle East & Africa Cytogenetics Market Outlook, By Pharmaceutical and Biotechnology Company (2021-2030) ($MN)
  • Table 155 Middle East & Africa Cytogenetics Market Outlook, By Academic Research Institute (2021-2030) ($MN)
  • Table 156 Middle East & Africa Cytogenetics Market Outlook, By Other End Users (2021-2030) ($MN)